Categories
Life Sciences Consumer Goods Materials and Chemicals Construction & Manufacturing Food and Beverages Energy and Power Semiconductor and Electronics Automotive and Transportation ICT & Media Aerospace & Defense BFSI

Int'l : +1-503-894-6022 | Toll Free : +1-800-792-5285 | help@alliedmarketresearch.com

Eye Care Surgical Market by Application (Cataract Surgery, Oculoplastic Surgery, Vitreo-Retinal Surgery, Corneal Surgery, Refractive Surgery, Glaucoma Surgery, Others) and by End User (Hospitals, Ophthalmology Clinics, Eye Research Institutes, Ambulatory Surgical Centers): Global Opportunity Analysis and Industry Forecast, 2023-2032

A03489

Pages: NA

Charts: NA

Tables: NA

Eye care involves examining of the eyes to detect abnormalities or defects and provide medical diagnosis & management of eye disease. An eye is a delicate organ, which requires continuous care before, during, and after a surgical procedure. Surgical devices are used to treat various eye-related diseases such as cataract, glaucoma, and refractive error, which pose as a health burden globally.

The major factors that contribute to the growth of the eye care surgical market include increasing prevalence of eye-related diseases such as glaucoma, cataract, diabetic retinopathy, refractive errors, increasing geriatric population, echnological advancements, high demand for diagnostic procedures, and minimally invasive procedures. However, factors such as high costs of devices and dearth of skilled professionals with expertise in ophthalmic surgery can restrain the growth of the market. The development of advanced products such as advances in laser technology and increasing healthcare infrastructure in untapped markets provide numerous opportunities for the market growth during the forecast period.

The eye care surgical market is segmented on the basis of application, end user, and region. According to application, the market is divided into cataract surgery, glaucoma surgery, refractive surgery, corneal surgery, vitreo-retinal surgery, oculoplastic surgery, and others, which include eye removal and eye muscle surgery. On the basis of end user, the market is segmented hospitals, ambulatory surgical centers, ophthalmology clinics, and eye research institutes. Geographically, the market has been analyzed across North America, Europe, Asia-Pacific, and LAMEA.

The key players that operate in this market include Bausch & Lomb Incorporated, Novartis AG, Abbott Laboartories, LUMENIS, Topcon Corporation, Carl Zeiss Meditec AG, Valeant Pharmaceuticals International Inc., Essilor, A.R.C. Laser GmbH, and Ophthalmic Instruments Inc.

Key Benefits

  • The study provides an in-depth analysis of the global eye care surgical market with current trends and future estimations to elucidate imminent investment pockets.
  • The report provides information about the current and upcoming trends in the global eye care surgical market which helps determine prevailing opportunities.
  • Comprehensive analysis of factors that drive and restrict the growth of the global eye care surgical market has been provided.
  • Identification of factors that are instrumental in changing the market scenario, rise in opportunities, and identification of key companies that can influence this market on a global and regional scale have been provided.
  • Key market players within the market have been profiled in this report and their strategies thoroughly analyzed, which help understand the competitive outlook of the global eye care surgical market.

 Key Market Segments

  • By Application
    • Cataract Surgery
    • Oculoplastic Surgery
    • Vitreo-Retinal Surgery
    • Corneal Surgery
    • Refractive Surgery
    • Glaucoma Surgery
    • Others
  • By End User
    • Hospitals
    • Ophthalmology Clinics
    • Eye Research Institutes
    • Ambulatory Surgical Centers
  • By Region
    • North America
      • U.S.
      • Canada
      • Mexico
    • Europe
      • France
      • Germany
      • Italy
      • Spain
      • UK
      • Rest of Europe
    • Asia-Pacific
      • China
      • Japan
      • India
      • South Korea
      • Australia
      • Rest of Asia-Pacific
    • LAMEA
      • Brazil
      • South Africa
      • Saudi Arabia
      • Rest of LAMEA

 
Key Market Players

  • A.R.C. Laser GmbH
  • Abbott Laboartories
  • LUMENIS
  • Topcon Corporation
  • Essilor
  • Ophthalmic Instruments Inc.
  • Carl Zeiss Meditec AG
  • Novartis AG
  • Bausch & Lomb Incorporated
  • Valeant Pharmaceuticals International Inc.

  • CHAPTER 1: INTRODUCTION

    • 1.1. Report Description

    • 1.2. Key Market Segments

    • 1.3. Key Benefits

    • 1.4. Research Methodology

      • 1.4.1. Primary Research

      • 1.4.2. Secondary Research

      • 1.4.3. Analyst Tools and Models

  • CHAPTER 2: EXECUTIVE SUMMARY

    • 2.1. CXO Perspective

  • CHAPTER 3: MARKET LANDSCAPE

    • 3.1. Market Definition and Scope

    • 3.2. Key Findings

      • 3.2.1. Top Investment Pockets

      • 3.2.2. Top Winning Strategies

    • 3.3. Porter's Five Forces Analysis

      • 3.3.1. Bargaining Power of Suppliers

      • 3.3.2. Threat of New Entrants

      • 3.3.3. Threat of Substitutes

      • 3.3.4. Competitive Rivalry

      • 3.3.5. Bargaining Power among Buyers

    • 3.5. Market Dynamics

      • 3.5.1. Drivers

      • 3.5.2. Restraints

      • 3.5.3. Opportunities

  • CHAPTER 4: EYE CARE SURGICAL MARKET, BY APPLICATION

    • 4.1. Market Overview

      • 4.1.1 Market Size and Forecast, By Application

    • 4.2. Cataract Surgery

      • 4.2.1. Key Market Trends, Growth Factors and Opportunities

      • 4.2.2. Market Size and Forecast, By Region

      • 4.2.3. Market Share Analysis, By Country

    • 4.3. Oculoplastic Surgery

      • 4.3.1. Key Market Trends, Growth Factors and Opportunities

      • 4.3.2. Market Size and Forecast, By Region

      • 4.3.3. Market Share Analysis, By Country

    • 4.4. Vitreo-Retinal Surgery

      • 4.4.1. Key Market Trends, Growth Factors and Opportunities

      • 4.4.2. Market Size and Forecast, By Region

      • 4.4.3. Market Share Analysis, By Country

    • 4.5. Corneal Surgery

      • 4.5.1. Key Market Trends, Growth Factors and Opportunities

      • 4.5.2. Market Size and Forecast, By Region

      • 4.5.3. Market Share Analysis, By Country

    • 4.6. Refractive Surgery

      • 4.6.1. Key Market Trends, Growth Factors and Opportunities

      • 4.6.2. Market Size and Forecast, By Region

      • 4.6.3. Market Share Analysis, By Country

    • 4.7. Glaucoma Surgery

      • 4.7.1. Key Market Trends, Growth Factors and Opportunities

      • 4.7.2. Market Size and Forecast, By Region

      • 4.7.3. Market Share Analysis, By Country

    • 4.8. Others

      • 4.8.1. Key Market Trends, Growth Factors and Opportunities

      • 4.8.2. Market Size and Forecast, By Region

      • 4.8.3. Market Share Analysis, By Country

  • CHAPTER 5: EYE CARE SURGICAL MARKET, BY END USER

    • 5.1. Market Overview

      • 5.1.1 Market Size and Forecast, By End User

    • 5.2. Hospitals

      • 5.2.1. Key Market Trends, Growth Factors and Opportunities

      • 5.2.2. Market Size and Forecast, By Region

      • 5.2.3. Market Share Analysis, By Country

    • 5.3. Ophthalmology Clinics

      • 5.3.1. Key Market Trends, Growth Factors and Opportunities

      • 5.3.2. Market Size and Forecast, By Region

      • 5.3.3. Market Share Analysis, By Country

    • 5.4. Eye Research Institutes

      • 5.4.1. Key Market Trends, Growth Factors and Opportunities

      • 5.4.2. Market Size and Forecast, By Region

      • 5.4.3. Market Share Analysis, By Country

    • 5.5. Ambulatory Surgical Centers

      • 5.5.1. Key Market Trends, Growth Factors and Opportunities

      • 5.5.2. Market Size and Forecast, By Region

      • 5.5.3. Market Share Analysis, By Country

  • CHAPTER 6: EYE CARE SURGICAL MARKET, BY REGION

    • 6.1. Market Overview

      • 6.1.1 Market Size and Forecast, By Region

    • 6.2. North America

      • 6.2.1. Key Market Trends and Opportunities

      • 6.2.2. Market Size and Forecast, By Application

      • 6.2.3. Market Size and Forecast, By End User

      • 6.2.4. Market Size and Forecast, By Country

      • 6.2.5. U.S. Eye Care Surgical Market

        • 6.2.5.1. Market Size and Forecast, By Application
        • 6.2.5.2. Market Size and Forecast, By End User

      • 6.2.6. Canada Eye Care Surgical Market

        • 6.2.6.1. Market Size and Forecast, By Application
        • 6.2.6.2. Market Size and Forecast, By End User

      • 6.2.7. Mexico Eye Care Surgical Market

        • 6.2.7.1. Market Size and Forecast, By Application
        • 6.2.7.2. Market Size and Forecast, By End User

    • 6.3. Europe

      • 6.3.1. Key Market Trends and Opportunities

      • 6.3.2. Market Size and Forecast, By Application

      • 6.3.3. Market Size and Forecast, By End User

      • 6.3.4. Market Size and Forecast, By Country

      • 6.3.5. France Eye Care Surgical Market

        • 6.3.5.1. Market Size and Forecast, By Application
        • 6.3.5.2. Market Size and Forecast, By End User

      • 6.3.6. Germany Eye Care Surgical Market

        • 6.3.6.1. Market Size and Forecast, By Application
        • 6.3.6.2. Market Size and Forecast, By End User

      • 6.3.7. Italy Eye Care Surgical Market

        • 6.3.7.1. Market Size and Forecast, By Application
        • 6.3.7.2. Market Size and Forecast, By End User

      • 6.3.8. Spain Eye Care Surgical Market

        • 6.3.8.1. Market Size and Forecast, By Application
        • 6.3.8.2. Market Size and Forecast, By End User

      • 6.3.9. UK Eye Care Surgical Market

        • 6.3.9.1. Market Size and Forecast, By Application
        • 6.3.9.2. Market Size and Forecast, By End User

      • 6.3.10. Russia Eye Care Surgical Market

        • 6.3.10.1. Market Size and Forecast, By Application
        • 6.3.10.2. Market Size and Forecast, By End User

      • 6.3.11. Rest Of Europe Eye Care Surgical Market

        • 6.3.11.1. Market Size and Forecast, By Application
        • 6.3.11.2. Market Size and Forecast, By End User

    • 6.4. Asia-Pacific

      • 6.4.1. Key Market Trends and Opportunities

      • 6.4.2. Market Size and Forecast, By Application

      • 6.4.3. Market Size and Forecast, By End User

      • 6.4.4. Market Size and Forecast, By Country

      • 6.4.5. China Eye Care Surgical Market

        • 6.4.5.1. Market Size and Forecast, By Application
        • 6.4.5.2. Market Size and Forecast, By End User

      • 6.4.6. Japan Eye Care Surgical Market

        • 6.4.6.1. Market Size and Forecast, By Application
        • 6.4.6.2. Market Size and Forecast, By End User

      • 6.4.7. India Eye Care Surgical Market

        • 6.4.7.1. Market Size and Forecast, By Application
        • 6.4.7.2. Market Size and Forecast, By End User

      • 6.4.8. South Korea Eye Care Surgical Market

        • 6.4.8.1. Market Size and Forecast, By Application
        • 6.4.8.2. Market Size and Forecast, By End User

      • 6.4.9. Australia Eye Care Surgical Market

        • 6.4.9.1. Market Size and Forecast, By Application
        • 6.4.9.2. Market Size and Forecast, By End User

      • 6.4.10. Thailand Eye Care Surgical Market

        • 6.4.10.1. Market Size and Forecast, By Application
        • 6.4.10.2. Market Size and Forecast, By End User

      • 6.4.11. Malaysia Eye Care Surgical Market

        • 6.4.11.1. Market Size and Forecast, By Application
        • 6.4.11.2. Market Size and Forecast, By End User

      • 6.4.12. Indonesia Eye Care Surgical Market

        • 6.4.12.1. Market Size and Forecast, By Application
        • 6.4.12.2. Market Size and Forecast, By End User

      • 6.4.13. Rest of Asia Pacific Eye Care Surgical Market

        • 6.4.13.1. Market Size and Forecast, By Application
        • 6.4.13.2. Market Size and Forecast, By End User

    • 6.5. LAMEA

      • 6.5.1. Key Market Trends and Opportunities

      • 6.5.2. Market Size and Forecast, By Application

      • 6.5.3. Market Size and Forecast, By End User

      • 6.5.4. Market Size and Forecast, By Country

      • 6.5.5. Brazil Eye Care Surgical Market

        • 6.5.5.1. Market Size and Forecast, By Application
        • 6.5.5.2. Market Size and Forecast, By End User

      • 6.5.6. South Africa Eye Care Surgical Market

        • 6.5.6.1. Market Size and Forecast, By Application
        • 6.5.6.2. Market Size and Forecast, By End User

      • 6.5.7. Saudi Arabia Eye Care Surgical Market

        • 6.5.7.1. Market Size and Forecast, By Application
        • 6.5.7.2. Market Size and Forecast, By End User

      • 6.5.8. UAE Eye Care Surgical Market

        • 6.5.8.1. Market Size and Forecast, By Application
        • 6.5.8.2. Market Size and Forecast, By End User

      • 6.5.9. Argentina Eye Care Surgical Market

        • 6.5.9.1. Market Size and Forecast, By Application
        • 6.5.9.2. Market Size and Forecast, By End User

      • 6.5.10. Rest of LAMEA Eye Care Surgical Market

        • 6.5.10.1. Market Size and Forecast, By Application
        • 6.5.10.2. Market Size and Forecast, By End User

  • CHAPTER 7: COMPETITIVE LANDSCAPE

    • 7.1. Introduction

    • 7.2. Top Winning Strategies

    • 7.3. Product Mapping Of Top 10 Player

    • 7.4. Competitive Dashboard

    • 7.5. Competitive Heatmap

    • 7.6. Top Player Positioning, 2024

  • CHAPTER 8: COMPANY PROFILES

    • 8.1. Bausch And Lomb Incorporated

      • 8.1.1. Company Overview

      • 8.1.2. Key Executives

      • 8.1.3. Company Snapshot

      • 8.1.4. Operating Business Segments

      • 8.1.5. Product Portfolio

      • 8.1.6. Business Performance

      • 8.1.7. Key Strategic Moves and Developments

    • 8.2. Novartis AG

      • 8.2.1. Company Overview

      • 8.2.2. Key Executives

      • 8.2.3. Company Snapshot

      • 8.2.4. Operating Business Segments

      • 8.2.5. Product Portfolio

      • 8.2.6. Business Performance

      • 8.2.7. Key Strategic Moves and Developments

    • 8.3. Abbott Laboartories

      • 8.3.1. Company Overview

      • 8.3.2. Key Executives

      • 8.3.3. Company Snapshot

      • 8.3.4. Operating Business Segments

      • 8.3.5. Product Portfolio

      • 8.3.6. Business Performance

      • 8.3.7. Key Strategic Moves and Developments

    • 8.4. LUMENIS

      • 8.4.1. Company Overview

      • 8.4.2. Key Executives

      • 8.4.3. Company Snapshot

      • 8.4.4. Operating Business Segments

      • 8.4.5. Product Portfolio

      • 8.4.6. Business Performance

      • 8.4.7. Key Strategic Moves and Developments

    • 8.5. Topcon Corporation

      • 8.5.1. Company Overview

      • 8.5.2. Key Executives

      • 8.5.3. Company Snapshot

      • 8.5.4. Operating Business Segments

      • 8.5.5. Product Portfolio

      • 8.5.6. Business Performance

      • 8.5.7. Key Strategic Moves and Developments

    • 8.6. Carl Zeiss Meditec AG

      • 8.6.1. Company Overview

      • 8.6.2. Key Executives

      • 8.6.3. Company Snapshot

      • 8.6.4. Operating Business Segments

      • 8.6.5. Product Portfolio

      • 8.6.6. Business Performance

      • 8.6.7. Key Strategic Moves and Developments

    • 8.7. Valeant Pharmaceuticals International Inc.

      • 8.7.1. Company Overview

      • 8.7.2. Key Executives

      • 8.7.3. Company Snapshot

      • 8.7.4. Operating Business Segments

      • 8.7.5. Product Portfolio

      • 8.7.6. Business Performance

      • 8.7.7. Key Strategic Moves and Developments

    • 8.8. Essilor

      • 8.8.1. Company Overview

      • 8.8.2. Key Executives

      • 8.8.3. Company Snapshot

      • 8.8.4. Operating Business Segments

      • 8.8.5. Product Portfolio

      • 8.8.6. Business Performance

      • 8.8.7. Key Strategic Moves and Developments

    • 8.9. A.R.C. Laser GmbH

      • 8.9.1. Company Overview

      • 8.9.2. Key Executives

      • 8.9.3. Company Snapshot

      • 8.9.4. Operating Business Segments

      • 8.9.5. Product Portfolio

      • 8.9.6. Business Performance

      • 8.9.7. Key Strategic Moves and Developments

    • 8.10. Ophthalmic Instruments Inc.

      • 8.10.1. Company Overview

      • 8.10.2. Key Executives

      • 8.10.3. Company Snapshot

      • 8.10.4. Operating Business Segments

      • 8.10.5. Product Portfolio

      • 8.10.6. Business Performance

      • 8.10.7. Key Strategic Moves and Developments

  • LIST OF TABLES

  • TABLE 1. GLOBAL EYE CARE SURGICAL MARKET, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 2. GLOBAL EYE CARE SURGICAL MARKET FOR CATARACT SURGERY, BY REGION, 2025-2033 ($MILLION)
  • TABLE 3. GLOBAL EYE CARE SURGICAL MARKET FOR OCULOPLASTIC SURGERY, BY REGION, 2025-2033 ($MILLION)
  • TABLE 4. GLOBAL EYE CARE SURGICAL MARKET FOR VITREO-RETINAL SURGERY, BY REGION, 2025-2033 ($MILLION)
  • TABLE 5. GLOBAL EYE CARE SURGICAL MARKET FOR CORNEAL SURGERY, BY REGION, 2025-2033 ($MILLION)
  • TABLE 6. GLOBAL EYE CARE SURGICAL MARKET FOR REFRACTIVE SURGERY, BY REGION, 2025-2033 ($MILLION)
  • TABLE 7. GLOBAL EYE CARE SURGICAL MARKET FOR GLAUCOMA SURGERY, BY REGION, 2025-2033 ($MILLION)
  • TABLE 8. GLOBAL EYE CARE SURGICAL MARKET FOR OTHERS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 9. GLOBAL EYE CARE SURGICAL MARKET, BY END USER, 2025-2033 ($MILLION)
  • TABLE 10. GLOBAL EYE CARE SURGICAL MARKET FOR HOSPITALS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 11. GLOBAL EYE CARE SURGICAL MARKET FOR OPHTHALMOLOGY CLINICS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 12. GLOBAL EYE CARE SURGICAL MARKET FOR EYE RESEARCH INSTITUTES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 13. GLOBAL EYE CARE SURGICAL MARKET FOR AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 14. GLOBAL EYE CARE SURGICAL MARKET, BY REGION, 2025-2033 ($MILLION)
  • TABLE 15. NORTH AMERICA EYE CARE SURGICAL, BY REGION, 2025-2033 ($MILLION)
  • TABLE 16. NORTH AMERICA EYE CARE SURGICAL, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 17. NORTH AMERICA EYE CARE SURGICAL, BY END USER, 2025-2033 ($MILLION)
  • TABLE 18. U.S. EYE CARE SURGICAL, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 19. U.S. EYE CARE SURGICAL, BY END USER, 2025-2033 ($MILLION)
  • TABLE 20. CANADA EYE CARE SURGICAL, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 21. CANADA EYE CARE SURGICAL, BY END USER, 2025-2033 ($MILLION)
  • TABLE 22. MEXICO EYE CARE SURGICAL, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 23. MEXICO EYE CARE SURGICAL, BY END USER, 2025-2033 ($MILLION)
  • TABLE 24. EUROPE EYE CARE SURGICAL, BY REGION, 2025-2033 ($MILLION)
  • TABLE 25. EUROPE EYE CARE SURGICAL, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 26. EUROPE EYE CARE SURGICAL, BY END USER, 2025-2033 ($MILLION)
  • TABLE 27. FRANCE EYE CARE SURGICAL, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 28. FRANCE EYE CARE SURGICAL, BY END USER, 2025-2033 ($MILLION)
  • TABLE 29. GERMANY EYE CARE SURGICAL, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 30. GERMANY EYE CARE SURGICAL, BY END USER, 2025-2033 ($MILLION)
  • TABLE 31. ITALY EYE CARE SURGICAL, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 32. ITALY EYE CARE SURGICAL, BY END USER, 2025-2033 ($MILLION)
  • TABLE 33. SPAIN EYE CARE SURGICAL, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 34. SPAIN EYE CARE SURGICAL, BY END USER, 2025-2033 ($MILLION)
  • TABLE 35. UK EYE CARE SURGICAL, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 36. UK EYE CARE SURGICAL, BY END USER, 2025-2033 ($MILLION)
  • TABLE 37. RUSSIA EYE CARE SURGICAL, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 38. RUSSIA EYE CARE SURGICAL, BY END USER, 2025-2033 ($MILLION)
  • TABLE 39. REST OF EUROPE EYE CARE SURGICAL, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 40. REST OF EUROPE EYE CARE SURGICAL, BY END USER, 2025-2033 ($MILLION)
  • TABLE 41. ASIA-PACIFIC EYE CARE SURGICAL, BY REGION, 2025-2033 ($MILLION)
  • TABLE 42. ASIA-PACIFIC EYE CARE SURGICAL, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 43. ASIA-PACIFIC EYE CARE SURGICAL, BY END USER, 2025-2033 ($MILLION)
  • TABLE 44. CHINA EYE CARE SURGICAL, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 45. CHINA EYE CARE SURGICAL, BY END USER, 2025-2033 ($MILLION)
  • TABLE 46. JAPAN EYE CARE SURGICAL, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 47. JAPAN EYE CARE SURGICAL, BY END USER, 2025-2033 ($MILLION)
  • TABLE 48. INDIA EYE CARE SURGICAL, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 49. INDIA EYE CARE SURGICAL, BY END USER, 2025-2033 ($MILLION)
  • TABLE 50. SOUTH KOREA EYE CARE SURGICAL, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 51. SOUTH KOREA EYE CARE SURGICAL, BY END USER, 2025-2033 ($MILLION)
  • TABLE 52. AUSTRALIA EYE CARE SURGICAL, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 53. AUSTRALIA EYE CARE SURGICAL, BY END USER, 2025-2033 ($MILLION)
  • TABLE 54. THAILAND EYE CARE SURGICAL, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 55. THAILAND EYE CARE SURGICAL, BY END USER, 2025-2033 ($MILLION)
  • TABLE 56. MALAYSIA EYE CARE SURGICAL, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 57. MALAYSIA EYE CARE SURGICAL, BY END USER, 2025-2033 ($MILLION)
  • TABLE 58. INDONESIA EYE CARE SURGICAL, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 59. INDONESIA EYE CARE SURGICAL, BY END USER, 2025-2033 ($MILLION)
  • TABLE 60. REST OF ASIA PACIFIC EYE CARE SURGICAL, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 61. REST OF ASIA PACIFIC EYE CARE SURGICAL, BY END USER, 2025-2033 ($MILLION)
  • TABLE 62. LAMEA EYE CARE SURGICAL, BY REGION, 2025-2033 ($MILLION)
  • TABLE 63. LAMEA EYE CARE SURGICAL, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 64. LAMEA EYE CARE SURGICAL, BY END USER, 2025-2033 ($MILLION)
  • TABLE 65. BRAZIL EYE CARE SURGICAL, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 66. BRAZIL EYE CARE SURGICAL, BY END USER, 2025-2033 ($MILLION)
  • TABLE 67. SOUTH AFRICA EYE CARE SURGICAL, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 68. SOUTH AFRICA EYE CARE SURGICAL, BY END USER, 2025-2033 ($MILLION)
  • TABLE 69. SAUDI ARABIA EYE CARE SURGICAL, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 70. SAUDI ARABIA EYE CARE SURGICAL, BY END USER, 2025-2033 ($MILLION)
  • TABLE 71. UAE EYE CARE SURGICAL, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 72. UAE EYE CARE SURGICAL, BY END USER, 2025-2033 ($MILLION)
  • TABLE 73. ARGENTINA EYE CARE SURGICAL, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 74. ARGENTINA EYE CARE SURGICAL, BY END USER, 2025-2033 ($MILLION)
  • TABLE 75. REST OF LAMEA EYE CARE SURGICAL, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 76. REST OF LAMEA EYE CARE SURGICAL, BY END USER, 2025-2033 ($MILLION)
  • TABLE 77. BAUSCH AND LOMB INCORPORATED: KEY EXECUTIVES
  • TABLE 78. BAUSCH AND LOMB INCORPORATED: COMPANY SNAPSHOT
  • TABLE 79. BAUSCH AND LOMB INCORPORATED: OPERATING SEGMENTS
  • TABLE 80. BAUSCH AND LOMB INCORPORATED: PRODUCT PORTFOLIO
  • TABLE 81. BAUSCH AND LOMB INCORPORATED: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 82. NOVARTIS AG: KEY EXECUTIVES
  • TABLE 83. NOVARTIS AG: COMPANY SNAPSHOT
  • TABLE 84. NOVARTIS AG: OPERATING SEGMENTS
  • TABLE 85. NOVARTIS AG: PRODUCT PORTFOLIO
  • TABLE 86. NOVARTIS AG: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 87. ABBOTT LABOARTORIES: KEY EXECUTIVES
  • TABLE 88. ABBOTT LABOARTORIES: COMPANY SNAPSHOT
  • TABLE 89. ABBOTT LABOARTORIES: OPERATING SEGMENTS
  • TABLE 90. ABBOTT LABOARTORIES: PRODUCT PORTFOLIO
  • TABLE 91. ABBOTT LABOARTORIES: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 92. LUMENIS: KEY EXECUTIVES
  • TABLE 93. LUMENIS: COMPANY SNAPSHOT
  • TABLE 94. LUMENIS: OPERATING SEGMENTS
  • TABLE 95. LUMENIS: PRODUCT PORTFOLIO
  • TABLE 96. LUMENIS: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 97. TOPCON CORPORATION: KEY EXECUTIVES
  • TABLE 98. TOPCON CORPORATION: COMPANY SNAPSHOT
  • TABLE 99. TOPCON CORPORATION: OPERATING SEGMENTS
  • TABLE 100. TOPCON CORPORATION: PRODUCT PORTFOLIO
  • TABLE 101. TOPCON CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 102. CARL ZEISS MEDITEC AG: KEY EXECUTIVES
  • TABLE 103. CARL ZEISS MEDITEC AG: COMPANY SNAPSHOT
  • TABLE 104. CARL ZEISS MEDITEC AG: OPERATING SEGMENTS
  • TABLE 105. CARL ZEISS MEDITEC AG: PRODUCT PORTFOLIO
  • TABLE 106. CARL ZEISS MEDITEC AG: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 107. VALEANT PHARMACEUTICALS INTERNATIONAL INC.: KEY EXECUTIVES
  • TABLE 108. VALEANT PHARMACEUTICALS INTERNATIONAL INC.: COMPANY SNAPSHOT
  • TABLE 109. VALEANT PHARMACEUTICALS INTERNATIONAL INC.: OPERATING SEGMENTS
  • TABLE 110. VALEANT PHARMACEUTICALS INTERNATIONAL INC.: PRODUCT PORTFOLIO
  • TABLE 111. VALEANT PHARMACEUTICALS INTERNATIONAL INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 112. ESSILOR: KEY EXECUTIVES
  • TABLE 113. ESSILOR: COMPANY SNAPSHOT
  • TABLE 114. ESSILOR: OPERATING SEGMENTS
  • TABLE 115. ESSILOR: PRODUCT PORTFOLIO
  • TABLE 116. ESSILOR: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 117. A.R.C. LASER GMBH: KEY EXECUTIVES
  • TABLE 118. A.R.C. LASER GMBH: COMPANY SNAPSHOT
  • TABLE 119. A.R.C. LASER GMBH: OPERATING SEGMENTS
  • TABLE 120. A.R.C. LASER GMBH: PRODUCT PORTFOLIO
  • TABLE 121. A.R.C. LASER GMBH: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 122. OPHTHALMIC INSTRUMENTS INC.: KEY EXECUTIVES
  • TABLE 123. OPHTHALMIC INSTRUMENTS INC.: COMPANY SNAPSHOT
  • TABLE 124. OPHTHALMIC INSTRUMENTS INC.: OPERATING SEGMENTS
  • TABLE 125. OPHTHALMIC INSTRUMENTS INC.: PRODUCT PORTFOLIO
  • TABLE 126. OPHTHALMIC INSTRUMENTS INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS

  • LIST OF FIGURES

  • FIGURE 1. GLOBAL EYE CARE SURGICAL MARKET SEGMENTATION
  • FIGURE 2. GLOBAL EYE CARE SURGICAL MARKET
  • FIGURE 3. SEGMENTATION EYE CARE SURGICAL MARKET
  • FIGURE 4. TOP INVESTMENT POCKET IN EYE CARE SURGICAL MARKET
  • FIGURE 5. MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 6. MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 7. MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 8. LOW THREAT OF SUBSTITUTION
  • FIGURE 9. HIGH COMPETITIVE RIVALRY
  • FIGURE 10. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALEYE CARE SURGICAL MARKET
  • FIGURE 11. EYE CARE SURGICAL MARKET SEGMENTATION, BY BY APPLICATION
  • FIGURE 12. EYE CARE SURGICAL MARKET FOR CATARACT SURGERY, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 13. EYE CARE SURGICAL MARKET FOR OCULOPLASTIC SURGERY, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 14. EYE CARE SURGICAL MARKET FOR VITREO-RETINAL SURGERY, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 15. EYE CARE SURGICAL MARKET FOR CORNEAL SURGERY, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 16. EYE CARE SURGICAL MARKET FOR REFRACTIVE SURGERY, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 17. EYE CARE SURGICAL MARKET FOR GLAUCOMA SURGERY, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 18. EYE CARE SURGICAL MARKET FOR OTHERS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 19. EYE CARE SURGICAL MARKET SEGMENTATION, BY BY END USER
  • FIGURE 20. EYE CARE SURGICAL MARKET FOR HOSPITALS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 21. EYE CARE SURGICAL MARKET FOR OPHTHALMOLOGY CLINICS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 22. EYE CARE SURGICAL MARKET FOR EYE RESEARCH INSTITUTES, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 23. EYE CARE SURGICAL MARKET FOR AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 24. TOP WINNING STRATEGIES, BY YEAR, 2022-2024*
  • FIGURE 25. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2022-2024*
  • FIGURE 26. TOP WINNING STRATEGIES, BY COMPANY, 2022-2024*
  • FIGURE 27. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 28. COMPETITIVE DASHBOARD
  • FIGURE 29. COMPETITIVE HEATMAP: EYE CARE SURGICAL MARKET
  • FIGURE 30. TOP PLAYER POSITIONING, 2024
  • FIGURE 31. BAUSCH AND LOMB INCORPORATED: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 32. BAUSCH AND LOMB INCORPORATED: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 33. BAUSCH AND LOMB INCORPORATED: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 34. NOVARTIS AG: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 35. NOVARTIS AG: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 36. NOVARTIS AG: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 37. ABBOTT LABOARTORIES: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 38. ABBOTT LABOARTORIES: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 39. ABBOTT LABOARTORIES: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 40. LUMENIS: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 41. LUMENIS: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 42. LUMENIS: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 43. TOPCON CORPORATION: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 44. TOPCON CORPORATION: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 45. TOPCON CORPORATION: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 46. CARL ZEISS MEDITEC AG: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 47. CARL ZEISS MEDITEC AG: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 48. CARL ZEISS MEDITEC AG: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 49. VALEANT PHARMACEUTICALS INTERNATIONAL INC.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 50. VALEANT PHARMACEUTICALS INTERNATIONAL INC.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 51. VALEANT PHARMACEUTICALS INTERNATIONAL INC.: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 52. ESSILOR: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 53. ESSILOR: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 54. ESSILOR: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 55. A.R.C. LASER GMBH: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 56. A.R.C. LASER GMBH: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 57. A.R.C. LASER GMBH: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 58. OPHTHALMIC INSTRUMENTS INC.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 59. OPHTHALMIC INSTRUMENTS INC.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 60. OPHTHALMIC INSTRUMENTS INC.: REVENUE SHARE, BY REGION, 2024 (%)

Purchase Full Report of
Eye Care Surgical Market

PURCHASE OPTIONS



* Taxes/Fees, If applicable will be added during checkout. All prices in USD.

Have a question ?

Need to add more ?

Avail up to 30% discount on subscription plans on


Avenue

© 2025 Allied Market Research. All Rights Reserved